AI assistant
Evolent Health, Inc. — Director's Dealing 2021
Jun 21, 2021
32214_dirs_2021-06-21_3c497bec-c288-40cd-be54-bdca12f6122a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Evolent Health, Inc. (EVH)
CIK: 0001628908
Period of Report: 2021-06-17
Reporting Person: WILLIAMS FRANK J (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-17 | Class A Common Stock | S | 10000 | $19.70 | Disposed | 648294 | Direct |
| 2021-06-17 | Class A Common Stock | M | 10000 | $3.84 | Acquired | 658294 | Direct |
| 2021-06-17 | Class A Common Stock | S | 10000 | $19.70 | Disposed | 648294 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-17 | Class A Common Stock Option (right to buy) | $3.84 | M | 10000 | Disposed | 2024-04-01 | Class A Common Stock (10000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 92848 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2021.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.53 to $19.91, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.461 to $19.9099, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: Shares held of record by the Williams 2019 GRAT. Mr. Williams serves as Trustee of the Williams 2019 GRAT.
F6: The Class A Common Stock Options exercised vested on December 1, 2014.